CRO

The CRO (Contract Research Organization) theme includes providers of outsourced R&D and clinical services to biopharma and med‑tech sponsors. Core tracks span preclinical discovery and toxicology, clinical trial operations (Phases I–IV), site management/SMO, data management and biostatistics, central labs and imaging, regulatory/medical writing and pharmacovigilance, eClinical platforms, and real‑world evidence.The sector's total market cap is 114.86 billion USD, with a 24h change of +7.55%. Among 5 constituents, 5 are up (100.00%) and 0 are down (0%). The top gainer is IQVIA Holdings Inc. (IQV), with a 24h increase of +14.09%.Momentum strengthened with broad-based gains and concentrated leadership. Near term, trade liquid leaders with tight risk; medium term, accumulate quality names paced by earnings visibility and interest-rate trends.